Skip to main content
Terug
Watch Compare

Aclarion, Inc.

Datakwaliteit: 100%
Ook genoteerd als ACONW Nasdaq
ACON
Nasdaq Services Health Services
€ 3,53
▼ € 0,04 (-1,12%)
Marktkapitalisatie: 8,06 M
Prijs
€ 3,53
Marktkapitalisatie
8,06 M
Dagbereik
€ 3,49 — € 3,94
52-Weeksbereik
€ 2,34 — € 12,03
Volume
479.579
Openen € 3,71
50D / 200D Gem.
€ 3,05
15,64% above
50D / 200D Gem.
€ 5,99
41,03% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -7,19 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)65,62%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-54,20%
Onder sectorgemiddelde (-15,95%)
ROIC-41,75%
Net Margin-9551,87%
Op. Margin-9312,55%

Veiligheid

Debt / Equity
N/A
Current Ratio17,01
Interest CoverageN/A

Waardering

PE (TTM)
-1,11
Boven sectorgemiddelde (-1,17)
P/B Ratio0,64
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -1,1 -1,2
P/B 0,6 1,4
ROE % -54,2 -16,0
Net Margin % -9551,9 -19,4
Rev Growth 5Y % 4,0
D/E 0,4

All Fundamental Metrics

Growth
Revenue Growth (1Y) 65,62% Revenue Growth (3Y) 0,22%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 75.730,0 Net Income (TTM) -7,23 M
ROE -54,20% ROA -51,75%
Gross Margin 9,02% Operating Margin -9312,55%
Net Margin -9551,87% Free Cash Flow (TTM) -7,19 M
ROIC -41,75% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 17,01
Interest Coverage N/A Asset Turnover 0,01
Working Capital 11,20 M Tangible Book Value 11,22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,11 Forward P/E N/A
P/B Ratio 0,64 P/S Ratio 106,39
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -89,19%
Market Cap 8,06 M Enterprise Value -3,28 M
Per Share
EPS (Diluted TTM) -13,61 Revenue / Share 0,03
FCF / Share -3,15 OCF / Share -3,14
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 28,43% FCF Conversion 99,34%
SBC-Adj. FCF -7,36 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 75.730,0 45.724,0 75.404,0 60.444,0
Net Income -7,23 M -6,99 M -4,91 M -7,61 M
EPS (Diluted) -13,61 -7480,00 -8,82 -1,31
Gross Profit 6.828,0 -38.934,0 -324,0 -4.854,0
Operating Income -7,05 M -5,51 M -4,88 M -6,10 M
EBITDA
R&D Expenses 1,03 M 888.766,0 873.336,0 1,09 M
SG&A Expenses
D&A 227.406,0 193.139,0 162.670,0 193.621,0
Interest Expense 64.084,0 608.288,0 1,51 M
Income Tax 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 13,67 M 2,12 M 2,46 M 3,21 M
Total Liabilities 837.287,0
Shareholders' Equity 12,84 M 970.057,0 -727.995,0 1,79 M
Total Debt
Cash & Equivalents 12,02 M 453.661,0 1,02 M 1,47 M
Current Assets 12,40 M 824.279,0 1,29 M 1,99 M
Current Liabilities 837.287,0 1,15 M 3,19 M 1,42 M